COVID-19 & Other Infectious Disease

View Available Technologies by Group

Below is a selection of available technologies.

For a complete listing or other questions contact Jessica Beach, Marketing Specialist at ott-market@emory.edu or 404-727-1899.

Technology Listings

TechIDTitleNon-Confidential Summary
1608Assay to Measure Cell Traction Forces for High Throughput Drug Screening and Mechanical PhenotypingTech Case: 1608 Summary
18012Antibodies for Zika and Dengue VirusesTech Case: 18012 Summary
14112Biomarkers for Diagnosis and Treatment Management of TuberculosisTech Case: 14112 Summary
10076Clinical Assay to Measure Activity of Phosphate Modifying EnzymesTech Case: 10076 Summary
NCS.07Cross-Reactive Antibodies Against Influenza VirusTech Case: NCS.07 Summary
16164Ebola Specific Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) AssayTech Case: 16164 Summary
17017Glycoprotein Tetramer for Identifying Antigen-specific B CellsTech Case: 17017 Summary
09116Normalization Procedure for Chemical Profiles in Biological or Medical Samples Detected by Mass SpectrometryTech Case: 09116 Summary
17100PrEP@Home: Testing Kit for Pre-Exposure Prophylaxis (PrEP) for HIVTech Case: 17100 Summary
13067Real Time Imaging of HIV with a PET/CT Total Body ScanTech Case: 13067 Summary
11034Shotgun Glycomics: A Microarray Strategy for Functional GlycomicsTech Case: 11034 Summary
NCS.24Specialized Cell Culturing Media for Enhanced Antibody Secretion and Plasma Cell SurvivalTech Case: NCS.24 Summary
17171TaqMan Array Cards for Pneumococcal Detection and Serotyping>Tech Case: 17171 Summary

Technology Listings

TechIDTitleNon-Confidential Summary
0708314-3-3  Isoform Expression Vectors and Recombinant Proteins for use in BioassaysTech Case: 07083 Summary
19053ADGRB1/BAI1 Knockout MouseTech Case: 19053 Summary
19054ADGRB3/BAI3 Knockout MouseTech Case: 19054 Summary
18012Antibodies for Zika and Dengue VirusesTech Case: 18012 Summary
07044Assay for Non-Nucleoside Inhibitors of the Measles and Nipah VirusesTech Case: 07044 Summary
06054Bulk Production of Optically Pure Sphingolipids and DerivativesTech Case: 06054 Summary
97059Counterselectable Vector for Gram+ BacteriaN/A
17002Helper Plasmids for Rescue of Respiratory Syncytial VirusTech Case: 17002 Summary
95034Human Lung Microvascular Endothelial Cell LineTech Case: 95034 Summary
04002Method for Tagging and Isolating CellsTech Case: 04002 Summary
14134Modified Respiratory Syncytial Virus (RSV) Strain for Drug Screening & Vaccine DevelopmentTech Case: 14134 Summary
05100Mouse Systems for Evaluating Antiviral Agent ToxicityTech Case: 05100 Summary
14165New Reagents for the Identification and Quantification of Most Pneumococcal Serotypes/Serogroups via Quantitative PCRN/A
11064Novel Tool for Respiratory Syncytial Virus (RSV) Vaccine Development & ResearchTech Case: 10064 Summary
RT011Plasmid for Respiratory Syncytial Virus (RSV) Vaccine Development & ResearchTech Case: RT011 Summary
97053Protein Phosphatase 2A Demethylase Protein and DNA SequencesTech Case: 97053 Summary
09091Recombinant Human Clonal Antibody B/Malaysia/2506/2004Tech Case: 09091 Summary
09095Recombinant Human Clonal Antibody - B/Shanghai/361/2004Tech Case: 09095 Summary
09093Recombinant Human Clonal Antibody - H1N1: A/New Caledonia/20/99Tech Case: 09093 Summary
09092Recombinant Human Clonal Antibody - H3N2: A/California/7/2004Tech Case: 09092 Summary
09094Recombinant Human Clonal Antibody - H3N2: A/Wisconsin/67/2005(2006/7)Tech Case: 09094 Summary
00046Recombinant Human Liver Monoamine Oxidase A and BTech Case: 00046 Summary
15117Recombinant Respiratory Syncytial Viruses (RSVs) Expressing the G and F Proteins from Various StrainsTech Case: 15117 Summary
12158Recombinant Respiratory Syncytial Virus (RSV) Strains Expressing Renilla Luciferase and G & F ProteinsTech Case: 12158 Summary
03026Reporter MouseTech Case: 03026 Summary
12118Research Tool for Vaccine Development for Respiratory Syncytial Virus (RSV)Tech Case: 12118 Summary
15062Respiratory Syncytial Virus (RSV) A2 Expressing Firefly LuciferaseTech Case: 15026 Summary
13073Respiratory Syncytial Virus (RSV) A/2001/2-20 Strain with Enhanced PathogenesisTech Case: 13073 Summary
16113Respiratory Syncytial Virus (RSV) A2 Expressing Firefly Luciferase and the F and G Genes of Clinical Strain A2001/2-20Tech Case: 16113 Summary
14099Respiratory Syncytial Virus (RSV) Fluorescent Reporter StrainTech Case: 14099 Summary
12073Respiratory Syncytial Virus (RSV) Luminescent Reporter StrainTech Case: 12073 Summary
12057Respiratory Syncytial Virus (RSV) Reporter Plasmid for High Throughput Drug ScreeningTech Case: 12057 Summary
15113Respiratory Syncytial Virus (RSV) Strain A2-2-20FTech Case: 15113 Summary
NCS.24Specialized Cell Culturing Media for Enhanced Antibody Secretion and Plasma Cell SurvivalTech Case: NCS.24 Summary
15145Tool for Measuring Cell Purity and Quality Control of Stem Cell-based ProductsTech Case: 15145 Summary
16111Transgenic Mice for Studying Cell-Type Specific ImmunityTech Case: 16111 Summary
08095Universal Expression VectorTech Case: 08095 Summary
13072Untagged Respiratory Syncytial Virus (RSV) A 2-line 19F Strain Generated from BAC-RSV CloneTech Case: 13072 Summary
02037Vectors for the Bacterial Expression of Human Deubiquitinating EnzymesTech Case: 02037 Summary

Technology Listings

TechIDTitleNon-Confidential Summary
18015Antibacterial Treatment for Gum DiseaseTech Case: 18015
10082Antibiotic Properties of Galectins Against Bacteria Expressing Host Cell Surface AntigensTech Case: 10082
18123Antibody Therapy for Varicella Zoster VirusTech Case: 18123
06054Bulk Production of Optically Pure Sphingolipids and DerivativesTech Case: 06054
11014CXCR4 Antagonists for the Treatment of CancerTech Case: 11014
19186Eradication of Pneumonococcal Carriage with Sodium DeoxycolateTech Case: 19186
10150Flagellin as a Therapeutic Agent to Treat Chronic Viral InfectionsTech Case: 10150
15107FIST-15: Interleukin 15, Sushi Domain, and TGF-ß Receptor Fusion Protein TherapeuticTech Case: 15107
13081Genetic Mutation in Immune Cells for Infectious Disease and Cancer TherapiesTech Case: 13081
12066GIFT4: GM-CSF and IL-4 Fusion Protein for Treating Cancer and Infectious DiseasesTech Case: 12066
11172GIFT7: A Novel Biologic to Treat Chronic Infections and CancerTech Case: 11172
13018GIFT9: GM-CSF and IL-9 Fusion Protein for the Treatment of Chronic Infections, Melanoma, or Other Solid TumorsN/A
16008Human Monoclonal Antibodies Against Ebola VirusTech Case: 16008
11045Inhibitors of Myxoviruses and Related Negative Strand RNA VirusesTech Case: 11045
14127Multi-Target CCR5/CXCR4 Chemokine Compounds for the Treatment of HIVTech Case: 14127
13157Recombinant Manufacturing Process for GIFT Fusion CytokinesTech Case: 130157
16002Repurposed Kinase Inhibitor for Treatment of Multidrug Resistant TuberculosisTech Case: 16002
12013Small Molecule Non-Nucleoside Inhibitors of the Measles VirusesTech Case: 12013
11212Therapeutic DNAzyme-Nanoparticle Conjugates for Gene RegulationTech Case: 11212

Technology Listing

TechIDTitleNon-Confidential Summary
14212Broad Spectrum Vaccine to Human Rhinovirus SerotypesTech Case: 14212 Summary
01037Compositions for Neisseria Vaccine DevelopmentTech Case: 01037 Summary
17017Glycoprotein Tetramer for Identifying Antigen-specific B CellsTech Case: 17017 Summary
11117Hepatitis C Virus (HCV) Mutants for Vaccine DevelopmentTech Case: 11117 Summary
07060HIV Vaccine Using Virus-Like Particles (VLPs)Tech Case: 07060 Summary
14216Membrane-anchored Fusokine as Vaccine Adjuvant to Prevent Viral InfectionTech Case: 14126 Summary
09116Normalization Procedure for Chemical Profiles in Biological or Medical Samples Detected by Mass SpectrometryTech Case: 09116 Summary
08061Novel Adjuvant for DNA-Based VaccineTech Case: 08061 Summary
13001Oral Vaccine for HIV ImmunizationTech Case: 13001 Summary
13126Repurposed Kinase Inhibitors as Vaccine AdjuvantsTech Case: 13126 Summary
08106Use of Dual Toll-Like Receptor (TLR) Ligands as Vaccine AdjuvantsN/A
17220Trimeric Immunogen for HIV-1 VaccinationTech Case: 17220 Summary
19024Virus-Like Particles as Respiratory Syncytial Virus (RSV) Vaccine CandidateTech Case: 19024 Summary